Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood

In Vivo

Volumn 21, Issue 3, 2007, Pages 493-498

  Nitsch, Stefan M ^a   Pries, Ralph ^a   Wollenberg, Barbara ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

CD34; HNSCC; IL 6; Immunomodulation; Stem cell

Indexed keywords

CD34 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8;

ANTIBODY LABELING; ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CD34 SELECTION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; MICROENVIRONMENT; SEPARATION TECHNIQUE; SQUAMOUS CELL CARCINOMA; STEM CELL; UMBILICAL CORD BLOOD;

EID: 34250155953     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Luce D, Guenel P, Leclerc A, Brugere J, Point and Rodriguez J: Alcohol and tobacco consumption in cancer of the mouth, pharynx, and larynx: a study of 316 female patients. Laryngoscope 98: 313-316, 1988.
2. Hartmann E, Wollenberg B, Rothenfusser S, Wagner M, Wellisch D, Mack B, Giese T, Gires O, Endres S and Hartmann G: Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res 63: 6478-6487, 2003.
3. Veltri RW, Rodman SM, Maxim PE, Baseler MW and Sprinkle PM: Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck. Cancer 57: 2295-2308, 1986.
4. Heimdal JH, Aarstad HJ and Olofsson J: Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma. Laryngoscope 110: 402-407, 2000.
5. Chin D, Boyle GM, Theile DR, Parsons PG and Coman WB: Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. Br J Plast Surg 57: 595-602, 2004.
6. Douglas WG, Tracy E, Tan D, Yu J, Hicks WL Jr, Rigual NR, Loree TR, Wang Y and Baumann H: Development of head and neck squamous cell carcinoma is associated with altered cytokine responsiveness. Mol Cancer Res 2: 585-593, 2004.
7. Pries R and Wollenberg B: Cytokines in head and neck cancer. Cytokine Growth Factor Rev 17: 141-146, 2006.
8. Pries R, Thiel A, Brocks C and Wollenberg B: Secretion of tumor-promoting and immune suppressive cyrokines by cell lines of head and neck squamous cell carcinoma. In Vivo 20: 45-48, 2006.
9. Mann EA, Spiro JD, Chen LL and Kreutzer DL: Cytokine expression by head and neck squamous cell carcinomas. Am J Surg 164: 567-573, 1992.
10. Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL and Van Waes C: Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5: 1369-1379, 1999.
11. Woods KV, El-Naggar A, Clayman GL and Grimm EA: Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens. Cancer Res 58: 3132-3141, 1998.
12. Eisma RJ, Spiro JD and Kreutzer DL: Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am J Surg 174: 513-517, 1997.
13. Young MR, Petruzzelli GJ, Kolesiak K, Achille N, Lathers DM and Gabrilovich DI: Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cells. Hum Immunol 62: 332-341, 2001.
14. Banich JC, Kolesiak K and Young MR: Chemoattraction of CD34+ progenitor cells and dendritic cells to the site of tumor excision as the first step of an immunotherapeutic approach to target residual tumor cells. J Immunother 26: 31-40, 2003.
15. Young MR, Farietta T and Crayton JW: Production of nitric oxide and transforming growth factor-beta in developing and adult rat brain. Mech Ageing Dev 79: 115-126, 1995.
16. Angulo I, Rodriguez R, Garcia B, Medina M, Navarro J and Subiza JL: Involvement of nitric oxide in bone marrow-derived natural suppressor activity. Its dependence on IFN-gamma. J Immunol 155: 15-26, 1995.
17. Young MR, Wright MA, Lozano Y, Matthews JP, Benefield J and Prechel M: Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer. Int J Cancer 67: 333-338, 1996.
18. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G and Schaper F: Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20, 2003.
19. Thomas GR, Chen Z, Leukinova E, Van Waes C and Wen J: Cytokines IL-1 alpha, IL-6, and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon gamma. Cancer Immunol Immunother 53: 33-40, 2004.
20. Seder RA and Paul WE: Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol 12: 635-673, 1994.
21. Kawamata H, Nakashiro K, Uchida D, Harada K, Yoshida H and Sato M: Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. Int J Cancer 70: 120-127, 1997.
22. Hartmann G, Weiner GJ and Krieg AM: CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 96: 9305-9310, 1999.
23. Sozzani S, Luini W, Borsatti A, Polentarutti N, Zhou D, Piemonti L, D'Amico G, Power CA, Wells TN, Gobbi M, Allavena P and Mantovani A: Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 159: 1993-2000, 1997.
24. Lathers DM and Young MR: Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine 25: 220-228, 2004.
25. Young MR: Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 53: 375-382, 2004.
26. Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM and Huang SC: Predominant Th2/ Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol 167: 2972-2978, 2001.
27. Blumenthal RD, Reising A, Leon E and Goldenberg DM: Modulation of marrow proliferation and chemosensitivity by tumor-produced cytokines from syngeneic pancreatic tumor lines. Clin Cancer Res 8: 1301-1309, 2002.
28. Lathers DM, Achille N, Kolesiak K, Hulett & Sparano A, Petruzzelli GJ and Young MR: Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cells. Otolaryngol Head Neck Surg 125: 205-212, 2001.
29. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997.